Comparative Evaluation of Biocompatibility Data from the Subcutaneous and the Calvaria Implantation Model of a Novel Bone Substitute Block
In Vivo · 2025
DOI: 10.21873/invivo.14113 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift In Vivo, 2025. Verfasst von Kim Burckhardt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany. Hauptthemen laut MEDLINE: Skull, Bone Substitutes, Biocompatible Materials, Materials Testing. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: This study compares the biocompatibility of a novel hybrid bone substitute material based on biphasic granules in a type I collagen scaffold using both subcutaneous and calvarial implantation models, in accordance with DIN EN ISO 10993-6. Given the distinct biological environments, materials may exhibit different behaviors in connective versus bone tissue. The aim was to evaluate irritation scores and cellular tissue responses to better understand the material's performance in both settings. MATERIALS AND METHODS: This study evaluated the biocompatibility and host tissue response of test materials in male Wistar rats through subcutaneous and calvaria implantation models, following DIN EN ISO 10993-6, assessing cellular responses, material degradation, and bone regeneration at 10-, 30-, and 60-days post-implantation. RESULTS: Subcutaneous implants elicited a stronger inflammatory reaction with higher counts of polymorphonuclear cells, lymphocytes, multinucleated giant cells, and plasma cells at day 10, alongside consistently elevated irritancy scores. In contrast, calvaria implants showed increased neovascularization, reflecting bone-specific regenerative processes. Although capsule formation and cellular infiltration were similar between models, material degradation and phagocytosis were significantly greater subcutaneously at day 60. CONCLUSION: These results highlight the critical impact of implantation site on immune activation, vascularization, and biomaterial resorption, underlining the importance of model selection in preclinical biomaterial assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.
- BerlinAnalytix GmbH, Berlin, Germany.
- Scientific Research Center for Biomedicine, Department for Cell and Tissue Engineering, Faculty of Medicine, University of Niš, Niš, Serbia.
- Department of Biology and Human Genetics, Faculty of Medicine, University of Niš, Niš, Serbia.
- University Medical Centre, Justus Liebig University of Giessen, Giessen, Germany.
- Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany; mike.barbeck@med.uni-rostock.de.
Zitieren
APA
Burckhardt, K., Jung, O., Stošić, M. R., Stojanović, S., Najman, S., Pantermehl, S., Schnettler, R., & Barbeck, M. (2025). Comparative Evaluation of Biocompatibility Data from the Subcutaneous and the Calvaria Implantation Model of a Novel Bone Substitute Block. In Vivo. https://doi.org/10.21873/invivo.14113
Vancouver
Burckhardt K, Jung O, Stošić MR, Stojanović S, Najman S, Pantermehl S, et al. Comparative Evaluation of Biocompatibility Data from the Subcutaneous and the Calvaria Implantation Model of a Novel Bone Substitute Block. In Vivo. 2025. doi:10.21873/invivo.14113
BibTeX
@article{Burckhardt2025,
author = {Burckhardt, Kim and Jung, Ole and Stošić, Milena Radenković and Stojanović, Sanja and Najman, Stevo and Pantermehl, Sven and Schnettler, Reinhard and Barbeck, Mike},
title = {Comparative Evaluation of Biocompatibility Data from the Subcutaneous and the Calvaria Implantation Model of a Novel Bone Substitute Block},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.14113}
}
EUVIMED